Works matching DE "PLASMA cell leukemia"
Results: 225
Plasma cell leukemia: Clinical manifestations and management.
- Published in:
- Onkologia i Radioterapia, 2024, v. 18, n. 8, p. 1
- By:
- Publication type:
- Article
Plasmacytosis without plasma cell disorder: beware of Dengue.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Laryngeal Involvement of Multiple Myeloma.
- Published in:
- Case Reports in Oncological Medicine, 2012, p. 1, doi. 10.1155/2012/257814
- By:
- Publication type:
- Article
Promyelocytic Leukemia Presenting as Acute Menorrhagia.
- Published in:
- Journal of South Asian Federation of Obstetrics & Gynecology, 2010, v. 2, n. 3, p. 220
- By:
- Publication type:
- Article
Étude transversale descriptive sur les profils cliniques et paracliniques des gammapathies monoclonales au niveau d'une région agricole du Souss-Massa au Maroc.
- Published in:
- Pan African Medical Journal, 2022, v. 41, p. 1, doi. 10.11604/pamj.2022.41.69.32470
- By:
- Publication type:
- Article
Primary plasma cell leukemia presenting as a thoracic mass.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP Workshop.
- Published in:
- American Journal of Clinical Pathology, 2023, v. 159, n. 6, p. 614, doi. 10.1093/ajcp/aqad034
- By:
- Publication type:
- Article
Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
- Published in:
- American Journal of Clinical Pathology, 2023, v. 159, n. 6, p. 598, doi. 10.1093/ajcp/aqad023
- By:
- Publication type:
- Article
Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1585, doi. 10.1007/s00520-012-1481-0
- By:
- Publication type:
- Article
Adipogenesis in Nonadherent and Adherent Bone Marrow Stem Cells Grown in Fibrin Gel and in the Presence of Adult Plasma.
- Published in:
- Cells Tissues Organs, 2007, v. 187, n. 3, p. 186, doi. 10.1159/000111804
- By:
- Publication type:
- Article
High-output heart failure associated with primary plasma cell leukaemia due to arteriovenous shunting: a case report.
- Published in:
- European Heart Journal Case Reports, 2021, v. 5, n. 9, p. 1, doi. 10.1093/ehjcr/ytab353
- By:
- Publication type:
- Article
Valor del fenotipaje mediante citometría de flujo en la confirmación del diagnóstico de leucemia de células plasmáticas.
- Published in:
- Revista Latinoamericana de Patología Clínica y Medicina de Laboratorio, 2012, v. 59, n. 3, p. 134
- By:
- Publication type:
- Article
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01159-8
- By:
- Publication type:
- Article
Extended DaraKRd: Are we enhancing outcomes by prolonging treatment?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01070-2
- By:
- Publication type:
- Article
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00998-9
- By:
- Publication type:
- Article
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 18, p. 2226, doi. 10.3390/cells12182226
- By:
- Publication type:
- Article
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 5, p. 838, doi. 10.3390/cells11050838
- By:
- Publication type:
- Article
Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1390747
- By:
- Publication type:
- Article
Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1217714
- By:
- Publication type:
- Article
Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 690, doi. 10.1038/leu.2013.335
- By:
- Publication type:
- Article
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 384, doi. 10.1038/leu.2013.199
- By:
- Publication type:
- Article
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 1, p. 155, doi. 10.1038/leu.2013.115
- By:
- Publication type:
- Article
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 1, p. 222, doi. 10.1038/leu.2013.241
- By:
- Publication type:
- Article
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 4, p. 780, doi. 10.1038/leu.2012.336
- By:
- Publication type:
- Article
Genetic aberrations and survival in plasma cell leukemia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 12, p. 2955, doi. 10.1080/10428194.2022.2098290
- By:
- Publication type:
- Article
Poor clinical outcome of elderly patients with primary plasma cell leukemia treated with novel agents: real-world experience.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 11, p. 2691, doi. 10.1080/10428194.2022.2086250
- By:
- Publication type:
- Article
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 2, p. 385, doi. 10.1080/10428194.2021.1983568
- By:
- Publication type:
- Article
Primary plasma cell leukemia presenting as secondary pulmonary alveolar proteinosis.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Plasma cell leukemia: update on biology and therapy.
- Published in:
- Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1538, doi. 10.1080/10428194.2016.1250263
- By:
- Publication type:
- Article
Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.
- Published in:
- Leukemia & Lymphoma, 2016, v. 57, n. 4, p. 927, doi. 10.3109/10428194.2015.1094697
- By:
- Publication type:
- Article
Chromosome 8q24.1/ c-MYC abnormality: a marker for high-risk myeloma.
- Published in:
- Leukemia & Lymphoma, 2015, v. 56, n. 3, p. 602, doi. 10.3109/10428194.2014.924116
- By:
- Publication type:
- Article
Extramedullary multiple myeloma.
- Published in:
- Leukemia & Lymphoma, 2013, v. 54, n. 6, p. 1135, doi. 10.3109/10428194.2012.740562
- By:
- Publication type:
- Article
Clinical and pathological features of testicular diffuse large B-cell lymphoma: a heterogeneous disease.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 2, p. 242, doi. 10.3109/10428194.2011.607528
- By:
- Publication type:
- Article
Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy.
- Published in:
- Leukemia & Lymphoma, 2008, v. 49, n. 10, p. 2012, doi. 10.1080/10428190802290660
- By:
- Publication type:
- Article
Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma.
- Published in:
- Leukemia & Lymphoma, 2008, v. 49, n. 2, p. 298, doi. 10.1080/10428190701760532
- By:
- Publication type:
- Article
Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia.
- Published in:
- Leukemia & Lymphoma, 2007, v. 48, n. 7, p. 1423, doi. 10.1080/10428190701361851
- By:
- Publication type:
- Article
Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.
- Published in:
- Leukemia & Lymphoma, 2007, v. 48, n. 7, p. 1426, doi. 10.1080/10428190701370597
- By:
- Publication type:
- Article
The treatment of the elderly multiple myeloma patients.
- Published in:
- Leukemia & Lymphoma, 2007, v. 48, n. 3, p. 469, doi. 10.1080/10428190601059852
- By:
- Publication type:
- Article
Managing plasma cell leukemia.
- Published in:
- Leukemia & Lymphoma, 2007, v. 48, n. 1, p. 5, doi. 10.1080/10428190600972527
- By:
- Publication type:
- Article
Reactive plasmacytoses can mimick plasma cell leukemia: Therapeutical implications.
- Published in:
- Leukemia & Lymphoma, 2007, v. 48, n. 1, p. 207, doi. 10.1080/10428190601016159
- By:
- Publication type:
- Article
Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome.
- Published in:
- Leukemia & Lymphoma, 2006, v. 47, n. 4, p. 715, doi. 10.1080/10428190500353216
- By:
- Publication type:
- Article
Plasma Cell Leukemia Occurring in a Patient with Thrombocythemia Treated with Hydroxyurea and Busulphan.
- Published in:
- Leukemia & Lymphoma, 2004, v. 45, n. 4, p. 821, doi. 10.1080/10428190310001615710
- By:
- Publication type:
- Article
Aggressive Primary Plasma Cell Leukemia With Skin Manifestations, Trisomy 8 and Molecular Oligoclonal Features.
- Published in:
- Leukemia & Lymphoma, 2002, v. 43, n. 5, p. 1067, doi. 10.1080/10428190290021696
- By:
- Publication type:
- Article
Relapsed Plasma Cell Leukaemia Presenting with Aggressive Extramedullary Plasmacytomas in the Meninges and Testis--A Missed Opportunity for Induction CNS Prophylaxis.
- Published in:
- Leukemia & Lymphoma, 2002, v. 43, n. 4, p. 893, doi. 10.1080/10428190290017060
- By:
- Publication type:
- Article
Thalidomide in Low Doses is Effective for the Treatment of Resistant or Relapsed Multiple Myeloma and for Plasma Cell Leukaemia.
- Published in:
- Leukemia & Lymphoma, 2002, v. 43, n. 2, p. 351, doi. 10.1080/10428190290006143
- By:
- Publication type:
- Article
Effects of Daratumumab on Hematopoietic Stem Cells in Patients with Multiple Myeloma Who Are Planned to Receive Autologous Transplantation: What's the Relevance?
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2024, v. 16, n. 1, p. 1, doi. 10.4084/MJHID.2024.073
- By:
- Publication type:
- Article
A Case of Fatal Hyperammonaemic Encephalopathy in a Patient with End-Stage Multiple Myeloma.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.012
- By:
- Publication type:
- Article
Ixazomib-Associated Skin Exfoliation.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.045
- By:
- Publication type:
- Article